• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Trending

Pinned News

Key facts: Sanofi trades at discount; offers low-cost medicines; plans price cuts

Event Tracking

Dec19
Sanofi Reaches Agreement with US Government to Lower Drug Costs and Promote Innovation
19:41
Sanofi Cuts Drug Prices and Plans to Upgrade Facilities in the US
19:23
Trump and multiple drug companies announce price cuts
17:45
Luisa Hector Maintains Buy Rating on Sanofi
08:12
Dec17
Sanofi's Aficamten Receives Marketing Approval in China
13:16
Sanofi's Efdoralprin alfa Drug Receives Orphan Drug Designation in the EU
06:45

Schedules & Filings

Schedules
Filings
Jan29
Earning Release(EST)

FY2025 Q4 Earning Release

Oct24
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 15.45 B, Net Income 3.286 B, EPS 2.6976

Jul31
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 12.57 B, Net Income 4.612 B, EPS 3.7893

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
LAZR
0.6044
+174.73%
+0.384
NBY
5.300
+79.66%
+2.350
MIMI
0.4795
+75.45%
+0.206
AZI
2.500
+64.47%
+0.980
GDC
5.260
+51.59%
+1.790
SOS
2.200
+47.65%
+0.710
IBO
0.6491
+46.26%
+0.205
FLYT
17.130
+45.42%
+5.350
CRWG
3.950
+45.22%
+1.230
CRWU
7.290
+44.93%
+2.260
View More